You are viewing: US Endoscopic Submucosal Dissection/ESD Market analysis

The US Endoscopic Submucosal Dissection/ESD Market was valued at $44.1 Million in 2025 and projected to reach to $67.7 Million by 2030, representing a compound annual growth rate of 9.0%. The US Endoscopic Submucosal Dissection market is poised for significant expansion through 2030, driven by growing awareness of minimally invasive treatment benefits and improved clinical outcomes.

US Endoscopic Submucosal Dissection/ESD Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

US Endoscopic Submucosal Dissection/ESD Market Trends and Insights

  • This expansion reflects increasing adoption of minimally invasive endoscopic procedures across US healthcare systems, driven by rising prevalence of gastrointestinal cancers and polyps requiring advanced therapeutic intervention.
  • The US market benefits from strong healthcare infrastructure, high procedural reimbursement rates, and growing physician training in ESD techniques. In the US, demand for ESD is accelerating due to improved clinical outcomes compared to traditional surgical resection, coupled with shorter recovery times and reduced patient morbidity.
  • The US healthcare sector's emphasis on precision medicine and tissue-preserving techniques further supports market expansion through 2030.
  • Technological advancements in endoscopic instrumentation and growing awareness among US gastroenterologists are expected to sustain this upward trajectory, positioning the US as a key growth market within the global ESD landscape..

Key Market Statistics

  • CAGR (2025-2030) 9.0% CAGR
  • Market Size, 2025 ~USD 44.1 Million
  • Forecast, 2030 ~USD 67.7 Million
  • Country US

US Endoscopic Submucosal Dissection/ESD Market Overview

Market Valuation :

The US ESD market is valued at $44.1 million in 2025, with strong growth trajectory driven by increasing adoption of minimally invasive procedures in American healthcare facilities.

Robust Growth Rate :

The US market is expanding at a 9.0% CAGR from 2025 to 2030, outpacing the global growth rate of 8.4%, indicating accelerating demand within the United States.

Rising GI Cancer Prevalence :

Increasing incidence of gastrointestinal cancers and polyps in the US population is driving demand for advanced endoscopic treatment options like ESD procedures.

Healthcare System Adoption :

Major US healthcare systems and hospitals are increasingly integrating ESD technology into their endoscopy departments, supporting market expansion through 2030.

US Endoscopic Submucosal Dissection/ESD Market Dynamics

  • Healthcare providers across the country are investing in advanced endoscopic capabilities to address rising gastrointestinal cancer rates and complex polyp management.
  • Technological advancements in ESD equipment and increasing physician training programs are facilitating broader adoption across US medical centers. Reimbursement improvements and favorable regulatory environment continue to support market growth.
  • The shift toward value-based care and patient preference for minimally invasive procedures further accelerate ESD adoption.
  • As US healthcare systems prioritize cost-effective treatments with reduced patient recovery times, ESD procedures are becoming standard of care in leading gastroenterology departments nationwide..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • JOHNSON & JOHNSON

    Key Takeaways

    • The US ESD market is valued at $44.1 million in 2025 and will reach $67.7 million by 2030, growing at a 9.0% CAGR.
    • US adoption of ESD is driven by superior clinical outcomes, minimally invasive benefits, and strong reimbursement infrastructure.
    • Rising incidence of gastrointestinal cancers and polyps in the US population is fueling demand for advanced endoscopic therapeutic solutions.
    • Increased physician training and technological innovation in endoscopic instrumentation are accelerating ESD market penetration across US healthcare facilities.

    Endoscopic Submucosal Dissection/ESD Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment KNIVES (Product)
    Forecast Period 2025–2030
    Growth Rate CAGR of 8.4% from 2025 to 2030
    Largest Segment GASTROSCOPES & COLONOSCOPES (Product)
    Market Size Base Year (Billions) ~USD 0.5 (2025)
    Revenue Forecast (Billions) ~USD 0.75 (2030)
    Segments Covered Product, Indication, End User

    US Endoscopic Submucosal Dissection/ESD Market Report Segmentation

    3 segment dimensions are covered across the global market.

    By Product

    • Gastroscopes & Colonoscopes
    • Grasp/Clips
    • Graspers/Clips
    • Injection Agents
    • Knives
    • Other Products
    • Tissue Retractors

    By Indication

    • Colon Cancer
    • Esophageal Cancer
    • Stomach Cancer

    By End User

    • Ambulatory Surgical Centers
    • Hospitals
    • Other End Users
    • Specialty Clinics

    US: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2023–2030

    Segment20232024202520262027202820292030CAGR (%)
    AMBULATORY SURGICAL CENTERS13.514.415.917.118.720.422.124.18.7
    HOSPITALS48.351.957.362.168.174.581.388.99.2
    OTHER END USERS2.22.32.52.72.93.13.33.67.4
    SPECIALTY CLINICS16.117.218.920.322.1242628.28.4
    TOTAL80.185.894.5102.3111.7122132.8144.88.9

    Target Audience

    • Medical Device Manufacturers : ESD equipment and accessory manufacturers need US market data to develop localized product strategies, identify distribution channels, and forecast revenue potential in this high-growth segment.
    • Healthcare Providers & Hospitals : US hospital systems and gastroenterology centers require market insights to justify ESD program investments, benchmark adoption rates, and plan endoscopy department expansion.
    • Private Equity & Investors : Investment firms evaluating healthcare technology opportunities need comprehensive US market analysis to assess growth potential, competitive dynamics, and exit opportunities in the ESD sector.
    • Consulting & Strategy Firms : Management consultants advising healthcare clients need detailed US market data to develop market entry strategies, competitive positioning, and growth roadmaps for ESD-related businesses.
    • Insurance & Reimbursement Specialists : Payers and health insurance companies require US market intelligence to evaluate coverage policies, assess procedure adoption trends, and optimize reimbursement strategies for ESD procedures.

    Key Companies in the US Endoscopic Submucosal Dissection/ESD Market

    CompanyHQOwnershipStrongest segments
    OLYMPUS CORPORATIONJapanPublic CompanyGastrointestinal Solutions,Urology,Respiratory,
    MEDTRONICIrelandPublic CompanyCardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio (incl. Diabetes),
    FUJIFILM HOLDINGS CORPORATIONJapanPublic CompanyHealthcare (medical systems, CDMO, pharma, regenerative medicine, cosmetics/supplements),Electronics (display/touch, semiconductor and image sensor materials, storage/archiving, industrial equipment, fine chemicals),Business Innovation (office equipment, document solutions, graphic communications, inkjet heads),
    BOSTON SCIENTIFIC CORPORATIONUnited StatesPublic CompanyCardiovascular (structural heart, CRM, peripheral interventions, oncology),MedSurg – Endoscopy (GI, pancreaticobiliary, infection prevention, single-use scopes),MedSurg – Urology and Pelvic Health,
    SUMITOMO BAKELITE CO., LTD.JapanPublic CompanySemiconductor encapsulation and substrate materials,Phenolic molding compounds and industrial resins,Copper-clad laminates (phenolic and epoxy),
    CREO MEDICAL GROUP PLCUnited KingdomPublic CompanyCROMA platform and capital equipment,Speedboat Inject and multimodal endoscopic instruments,MicroBlate Fine and MicroBlate Flex ablation devices,
    HOYA CORPORATIONJapanPublic CompanyEyeglasses and ophthalmic lenses,Contact lenses and Eyecity retail,Intraocular lenses and surgical ophthalmology,
    CONMED CORPORATIONUnited StatesPublic CompanyOrthopedic & Sports Medicine (BioBrace, Y-Knot, TruShot, Hall power tools),General Surgery (AirSeal insufflation, Buffalo Filter smoke, endomechanical),Endoscopic Technologies (GI therapeutic and diagnostic),
    STERISIrelandPublic CompanyHealthcare sterilization and washer-disinfectors,Endoscope reprocessing systems and consumables,Operating room equipment and integration,

    OLYMPUS CORPORATION

    Olympus Corporation is a Japanese public company founded in 1919 with 28,138 employees. The company operates as a diversified manufacturer with significant operations in medical devices and imaging technology.

    MEDTRONIC

    Medtronic is a public company headquartered in Ireland, founded in 1949, with approximately 95,000 employees. It is a global leader in medical technology, services, and solutions.

    FUJIFILM HOLDINGS CORPORATION

    Fujifilm Holdings Corporation is a Japanese public company established in 1934 with 73,526 employees. The company operates across imaging, information, and document solutions, as well as healthcare and materials sectors.

    BOSTON SCIENTIFIC CORPORATION

    Boston Scientific Corporation is a United States-based public company founded in 1979 with 59,000 employees. It specializes in the development and manufacture of medical devices and technologies.

    SUMITOMO BAKELITE CO., LTD.

    Sumitomo Bakelite Co., Ltd. is a Japanese public company founded in 1932 with 7,524 employees. The company manufactures advanced materials and components for various industrial applications.

    CREO MEDICAL GROUP PLC

    Creo Medical Group PLC is a United Kingdom-based public company founded in 2003 with 104 employees. The company develops and commercializes medical devices and technologies.

    HOYA CORPORATION

    Hoya Corporation is a Japanese public company established in 1941 with 37,752 employees. The company manufactures optical products, medical devices, and precision equipment.

    CONMED CORPORATION

    CONMED Corporation is a United States-based public company founded in 1970 with 3,900 employees. The company designs, manufactures, and sells medical devices and equipment for surgical and patient monitoring applications.

    STERIS

    STERIS is a public company headquartered in Ireland, founded in 1985. The company provides sterilization and contamination control products and services for healthcare and industrial markets.

    Reasons to Buy this Report

    • Market Size & Growth Data : Access precise US market valuation ($44.1M in 2025) and forecast projections ($67.7M by 2030) with 9% CAGR to support strategic planning and investment decisions.
    • Competitive Landscape Analysis : Understand key players, market share distribution, and competitive positioning specific to the US ESD market to identify partnership and acquisition opportunities.
    • Regional Adoption Trends : Gain insights into US healthcare system adoption patterns, regional variations, and hospital integration rates to optimize market entry and expansion strategies.
    • Regulatory & Reimbursement Insights : Obtain detailed analysis of US FDA approvals, insurance coverage policies, and reimbursement trends affecting ESD procedure adoption and profitability.
    • Clinical & Market Drivers : Understand US-specific factors including GI cancer prevalence, physician training initiatives, and patient demand drivers shaping market growth through 2030.

    Frequently asked questions

    What is the current size of the US ESD market in 2025?

    The US Endoscopic Submucosal Dissection market is valued at $44.1 million in 2025.

    What is the projected size of the US ESD market by 2030?

    The US ESD market is forecast to reach $67.7 million by 2030, representing 53.4% growth over the five-year period.

    What is the CAGR for the US ESD market from 2025 to 2030?

    The US ESD market is expected to grow at a compound annual growth rate (CAGR) of 9.0% between 2025 and 2030.

    What factors are driving growth in the US ESD market?

    Key growth drivers in the US include rising gastrointestinal cancer prevalence, improved clinical outcomes versus surgery, strong healthcare reimbursement, and increased physician training in ESD techniques.

    Why is the US ESD market growing faster than the global average?

    The US market grows at 9.0% CAGR compared to the global 8.4% due to superior healthcare infrastructure, higher procedural reimbursement rates, and greater adoption of minimally invasive endoscopic techniques.

    RESEARCH METHODOLOGY

    The study focused on estimating the current size of the endoscopic submucosal dissection (ESD) market. We conducted thorough secondary research to gather information about the market. The next step involved validating our findings, assumptions, and estimates through primary research by consulting industry experts throughout the value chain. We used various approaches, including top-down and bottom-up methods, to calculate the total market size. Subsequently, we applied market breakdown and data triangulation techniques to estimate the sizes of different segments and subsegments within the ESD market.

    Secondary Research

    This research study heavily utilized secondary sources, including directories and databases such as Dun & Bradstreet, Bloomberg Businessweek, Factiva, whitepapers, and company documents. The purpose of the secondary research was to identify and gather information for a comprehensive, technical, market-oriented, and commercial analysis of the endoscopic submucosal dissection (ESD) market. It also aimed to collect vital information about leading industry players, market classification, and segmentation according to industry trends, down to the most granular levels, as well as geographic markets and key developments related to the market. Additionally, a database of key industry leaders was created based on the findings from the secondary research.

    Primary Research

    During the primary research process, a variety of supply-side and demand-side sources were interviewed to gather both qualitative and quantitative information for this report. On the supply side, primary sources included industry experts such as CEOs, vice presidents, marketing and sales directors, technology and innovation directors, engineers, and other key executives from various companies and organizations operating in the ESD market. On the demand side, primary sources encompassed hospitals, clinics, researchers, lab technicians, purchasing managers, and stakeholders from corporate and government bodies.

    Breakdown of Primary Interviews

    Endoscopic Submucosal Dissection Market

    Note 1: C-level executives include CEOs, COOs, and CTOs.

    Note 2: Others include sales, marketing, and product managers.

    Note 3: Companies are classified into tiers based on their total revenue. As of 2024: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the ESD market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    Endoscopic Submucosal Dissection Market

    Data Triangulation

    The entire market was split into three segments when the market size was determined. Data triangulation and market breakdown processes were used where necessary to complete the entire market engineering process and arrive at precise statistics for all segments.

    Approach to derive the market size and estimate market growth.

    Using secondary data from paid and unpaid sources, the market rankings for the major players were determined following a thorough analysis of their sales of ESD. Due to data restrictions, the revenue share in certain cases was determined after a thorough analysis of the product portfolio of big corporations and their individual sales performance. This information was verified at each stage by in-depth interviews with professionals in the field.

    Market Definition

    Endoscopic submucosal dissection (ESD) is an advanced therapeutic endoscopy technique for superficial gastrointestinal neoplasms. In endoscopic submucosal dissection, the equipment includes different types of knives, forceps, snares, and a few other products that support the procedure, as well as accessories used to ease the handling of instruments during surgeries.

    Stakeholders

    • Manufacturers of endoscopes and related devices
    • Suppliers and distributors of endoscopy devices
    • Hospitals, diagnostic centers, and medical colleges
    • Independent surgeons and private offices of physicians
    • Ambulatory surgery centers (ASCs)
    • Teaching hospitals and academic medical centers
    • Government bodies/municipal corporations
    • Business research and consulting service providers
    • Venture capitalists
    • US Food and Drug Administration (US FDA)
    • European Union (EU)

    Report Objectives

    • To define, describe, and forecast the endoscopic submucosal dissection market by product, indication, end user, and region
    • To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
    • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall endoscopic submucosal dissection market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the endoscopic submucosal dissection market in six regions: North America (US and Canada), Europe (Germany, the UK, France, Spain, Italy, and the Rest of Europe), the Asia Pacific (Japan, China, India, Australia, South Korea, and the Rest of Asia Pacific), Latin America (Brazil, Mexico, and the Rest of Latin America), the Middle East & Africa, and the GCC Countries
    • To strategically profile the key players in the global market and comprehensively analyze their core competencies
    • To track and analyze competitive developments, such as product launches, expansions, agreements, and acquisitions, of the leading players in the market

    Get the Full Endoscopic Submucosal Dissection/ESD Market Report

    Full forecast, segment splits, and company analysis for all Endoscopic Submucosal Dissection/ESD Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status